Somavert

Active Ingredient(s): Pegvisomant
FDA Approved: * March 25, 2003
Pharm Company: * PHARMACIA AND UPJOHN
Category: Acromegaly

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Somavert Overview

Pegvisomant (trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.[1] It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy.[2] It is delivered as a powder that is mixed with water and injected under the skin.[3] Contents 1 Discovery 2 Struct...

Read more Somavert Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegvisomant

Recent Somavert Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Somavert: (10 results)

Sorted by National Drug Code

• 0009-5176 Somavert Kit by Pharmacia and Upjohn Company
• 0009-5178 Somavert Kit by Pharmacia and Upjohn Company
• 0009-5180 Somavert Kit by Pharmacia and Upjohn Company
• 0009-5199 Somavert Kit by Pharmacia and Upjohn Company
• 0009-5200 Somavert Kit by Pharmacia and Upjohn Company
• 0009-7166 Somavert Kit by Pharmacia and Upjohn Company LLC
• 0009-7168 Somavert Kit by Pharmacia and Upjohn Company LLC
• 0009-7188 Somavert Kit by Pharmacia and Upjohn Company LLC
• 0009-7199 Somavert Kit by Pharmacia and Upjohn Company LLC
• 0009-7200 Somavert Kit by Pharmacia and Upjohn Company LLC

Other drugs which contain Pegvisomant or a similar ingredient: (1 result)

• PEGVISOMANT